Ishita Drugs and Industries Limited - Laporan Laba Rugi (TTM)

Ishita Drugs and Industries Limited
IN ˙ BSE
₹ 79.90 0.00 (0.00%)
2025-04-22
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Ishita Drugs and Industries Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 135 133 139 145 136 141 141 146 145 134 121 118 134 133 152 151 140 149 150 174
Change (%) -1.15 4.81 4.20 -6.19 3.68 -0.32 3.30 -0.42 -7.41 -10.04 -2.21 13.21 -0.35 14.04 -0.39 -7.41 6.58 0.45 15.82
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 116 113 119 107 114 119 118 106 123 111 100 83 110 110 129 113 118 123 126 127
Change (%) -2.20 5.41 -10.15 6.66 4.43 -1.05 -10.15 15.95 -9.49 -10.12 -17.43 32.51 0.32 17.72 -13.02 5.18 3.69 2.77 0.34
% of Revenue 85.94 85.03 85.52 73.74 83.85 84.46 83.85 72.93 84.92 83.01 82.93 70.03 81.97 82.52 85.18 74.38 84.49 82.21 84.10 72.86
Gross Operating Profit 19 20 20 38 22 22 23 39 22 23 21 35 24 23 23 39 22 27 24 47
Change (%) 5.27 1.37 88.93 -42.30 -0.25 3.65 73.08 -44.51 4.27 -9.63 71.72 -31.88 -3.39 -3.36 72.24 -43.96 22.31 -10.24 97.72
% of Revenue 14.06 14.97 14.48 26.26 16.15 15.54 16.15 27.07 15.08 16.99 17.07 29.97 18.03 17.48 14.82 25.62 15.51 17.79 15.90 27.14
SG&A 11 11 11 11 11 11 12 12 12 13 13 13 14 14 13 14 14 14 14 13
Change (%) 0.84 0.58 0.81 1.53 0.39 4.68 1.89 2.69 4.19 0.50 -0.02 4.71 0.28 -1.57 2.24 -1.36 1.20 0.99 -3.38
% of Revenue 8.07 8.23 7.90 7.64 8.27 8.01 8.41 8.30 8.56 9.63 10.76 11.00 10.17 10.24 8.83 9.07 9.66 9.17 9.22 7.69
R&D
Change (%)
% of Revenue
OpEx 129 127 132 137 129 133 131 135 135 125 114 112 127 126 144 143 132 140 141 163
Change (%) -1.78 4.12 4.29 -6.41 3.76 -1.62 3.19 -0.19 -7.39 -8.65 -1.86 13.18 -0.87 14.25 -0.49 -8.00 6.43 0.60 15.59
% of Revenue 95.70 95.09 94.47 94.55 94.33 94.41 93.18 93.08 93.30 93.31 94.76 95.10 95.07 94.58 94.75 94.66 94.05 93.92 94.06 93.87
Operating Income 6 7 8 8 8 8 10 10 10 9 6 6 7 7 8 8 8 9 9 11
Change (%) 12.90 18.19 2.62 -2.45 2.35 21.57 4.75 -3.51 -7.68 -29.51 -8.56 13.86 9.72 10.29 1.48 3.08 8.94 -1.81 19.50
% of Revenue 4.30 4.91 5.53 5.45 5.67 5.59 6.82 6.92 6.70 6.69 5.24 4.90 4.93 5.42 5.25 5.34 5.95 6.08 5.94 6.13
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0 -0 -1 -1 -1 -1 -1 -0 -0 -0 -1
Change (%) -32.36 105.72 64.26 -22.27 -11.54 -79.49 451.73 108.49 -15.52 57.88 -38.67 14.85 -43.56 -56.25 96.17 153.23
% of Revenue -0.10 -0.07 -0.13 -0.21 -0.17 -0.15 -0.03 -0.16 -0.30 -0.64 -0.48 -0.76 -0.41 -0.47 -0.29 -0.12 -0.23 -0.50
Net Income 5 6 8 9 9 9 8 8 8 8 6 5 6 6 7 8 7 9 9 10
Change (%) 2.55 49.79 5.47 -1.37 2.04 -8.59 3.74 -2.65 -4.88 -25.33 -5.00 16.95 0.63 15.96 1.35 -2.02 15.97 0.71 17.84
% of Revenue 4.01 4.16 5.95 6.02 6.33 6.23 5.71 5.74 5.61 5.76 4.78 4.65 4.80 4.85 4.93 5.01 5.31 5.77 5.79 5.89

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista